Literature DB >> 16497504

Beta-nitrostyrene derivatives as potential antibacterial agents: a structure-property-activity relationship study.

Nuno Milhazes1, Rita Calheiros, M Paula M Marques, Jorge Garrido, M Natália D S Cordeiro, Cátia Rodrigues, Sandra Quinteira, Carla Novais, Luísa Peixe, Fernanda Borges.   

Abstract

A multidisciplinary project was developed, combining the synthesis of a series of beta-nitrostyrene derivatives and the determination of their physicochemical parameters (redox potentials, partition coefficients), to the evaluation of the corresponding antibacterial activity. A complete conformational analysis was also performed, in order to get relevant structural information. Subsequently, a structure-property-activity (SPAR) approach was applied, through linear regression analysis, aiming at obtaining a putative correlation between the physicochemical parameters of the compounds investigated and their antibacterial activity (both against standard strains and clinical isolates). The beta-nitrostyrene compounds displayed a lower activity towards all the tested bacteria relative to the beta-methyl-beta-nitrostyrene analogues. This was observed particularly for the 3-hydroxy-4-methoxy-beta-methyl-beta-nitrostyrene (IVb) against the Gram-positive bacteria (Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium). The SPAR results revealed the existence of a clear correlation between the redox potentials and the antibacterial activity of the series of beta-nitrostyrene derivatives under study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497504     DOI: 10.1016/j.bmc.2006.02.006

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Quantitative cell-based protein degradation assays to identify and classify drugs that target the ubiquitin-proteasome system.

Authors:  Tsui-Fen Chou; Raymond J Deshaies
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

2.  Osteosarcoma Phenotype Is Inhibited by 3,4-Methylenedioxy-β-nitrostyrene.

Authors:  Patrick J Messerschmitt; Ashley N Rettew; Nicholas O Schroeder; Robert E Brookover; Avanti P Jakatdar; Patrick J Getty; Edward M Greenfield
Journal:  Sarcoma       Date:  2012-05-31

3.  β-Nitrostyrenes as Potential Anti-leishmanial Agents.

Authors:  Syed Shafi; Farhat Afrin; Mohammad Islamuddin; Garima Chouhan; Intzar Ali; Faatima Naaz; Kalicharan Sharma; Mohammad S Zaman
Journal:  Front Microbiol       Date:  2016-09-01       Impact factor: 5.640

4.  The Synthetic β-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways.

Authors:  Wen-Chin Chiu; Yi-Chen Lee; Yu-Han Su; Yen-Yun Wang; Chun-Hao Tsai; Yi-An Hou; Chie-Hong Wang; Ying-Fong Huang; Chih-Jen Huang; Shah-Hwa Chou; Pei-Wen Hsieh; Shyng-Shiou F Yuan
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

5.  Nitropropenyl benzodioxole, an anti-infective agent with action as a protein tyrosine phosphatase inhibitor.

Authors:  Kylie S White; Gina Nicoletti; Robert Borland
Journal:  Open Med Chem J       Date:  2014-05-30

6.  Using mutability landscapes of a promiscuous tautomerase to guide the engineering of enantioselective Michaelases.

Authors:  Jan-Ytzen van der Meer; Harshwardhan Poddar; Bert-Jan Baas; Yufeng Miao; Mehran Rahimi; Andreas Kunzendorf; Ronald van Merkerk; Pieter G Tepper; Edzard M Geertsema; Andy-Mark W H Thunnissen; Wim J Quax; Gerrit J Poelarends
Journal:  Nat Commun       Date:  2016-03-08       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.